Figure 1
![Figure 1. Elevation of plasma L5 concentration in patients with STEMI. Fast-protein liquid chromatography analysis of LDL showing the content of each subfraction (L1-L5) in (A) normal control subjects with no cardiovascular risk factors and (B) patients with STEMI. The (C) L5% and (D) L5 plasma concentration ([L5]) for each subject is plotted. The line represents the mean of the group. The mean [L5] was significantly higher in STEMI patients (n = 30) than in control subjects (n = 30). ***P < .001, determined by using the Wilcoxon rank-sum test.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/122/22/10.1182_blood-2013-05-504639/4/3632f1.jpeg?Expires=1724126245&Signature=hKrxGudsO~EN91alKFCBx8GSMJ360xCVkQXjVH06vF1RdEHFBjTFEAwb4ojmrvrXmk3qF1NR2cV3lj9ZyEbbqdnGSsTrXkRvnMR4ZOJ0qKQ~~EfwIDNWGS1CwpPsv00okeYysQZxIJBPKAiQaNjxgsnm1HgQiteLOzeekXbwrZMDPWboZPUgY09FHP0OU9BdpCH62tMrEfYdWnqfIDGX5ICGzYzDlsOpBEBK0OMYWmfuWSRJde8xOVlAptvx~S17lpY-~Jbfwd0p00N0ksPQzqrbxQ4F3jPzst2bpc5hA7~TXrjAW~wdSWLf3HtbAd272vjUSlBBEZcqeiOPhqDUww__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Elevation of plasma L5 concentration in patients with STEMI. Fast-protein liquid chromatography analysis of LDL showing the content of each subfraction (L1-L5) in (A) normal control subjects with no cardiovascular risk factors and (B) patients with STEMI. The (C) L5% and (D) L5 plasma concentration ([L5]) for each subject is plotted. The line represents the mean of the group. The mean [L5] was significantly higher in STEMI patients (n = 30) than in control subjects (n = 30). ***P < .001, determined by using the Wilcoxon rank-sum test.
